WASHINGTON, D.C. 20549

                                   FORM 12b-25

        NOTIFICATION OF LATE FILING                         SEC FILE NUMBER
                                                            CUSPID NUMBER
                                                             00765D 10 6

[  ]Form 10-K and Form 10-KSB [  ]Form 20-F [  ]Form 11-K [X]Form  10-Q
    and Form 10-QSB [  ]Form N-SAR

    For Period Ended: September 30, 2005

    [ ] Transition Report on Form 10-K
    [ ] Transition Report on Form 20-F
    [ ] Transition Report on Form 11-K
    [ ] Transition Report on Form 10-Q
    [ ] Transition Report on Form N-SAR

                 For the Transition Period Ended: Not Applicable

      Nothing in this Form shall be construed to imply that the Commission has
verified any information contained herein.

      If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates: Not Applicable

Part I--Registrant Information

      Full Name of Registrant: Advanced Sports Technologies, Inc.

      Former Name if Applicable: Not Applicable

      Address of Principal Executive Office:

              2 Briar Lane
              Natick, Massachusetts 01760



Part II--Rules 12b-25 (b) and (c)

      If the subject report could not be filed without unreasonable effort or
expense and the Registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)

[X] (a) the reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;

[X] (b) The subject annual report, semi-annual report, transition report on Form
10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following the prescribed due
date; and

[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.


Part III--Narrative

      State below in reasonable detail the reasons why Form 10-K and Form
10-KSB, 20-F, 11-K, 10-Q and Form 10-QSB, N-SAR, or the transition report or
portion thereof could not be filed within the prescribed period.

      The Registrant is unable to file its Quarterly Report on Form 10-QSB for
the quarter ended September 30, 2005 within the prescribed period because of the
merger effectuated on September 23, 2005 between CardioBioMedical Corporation
and Advanced Sports Technologies, Inc. pursuant to the terms of an Agreement and
Plan of Merger dated September 23, 2005 (the "Merger Agreement"). As a result of
the Merger Agreement, the transaction was treated for accounting purposes as a
recapitalization by the accounting acquirer CardioBioMedical Corporation. This
recapitalization requires additional time to complete the preparation and filing
of its Quarterly Report on Form 10-QSB for the quarter ended September 30, 2005.


Part IV--Other Information

      (1) Name and telephone number of person to contact in regard to this

     James F. Mongiardo                  (508)                647-4065
          (Name)                      (Area Code)         (Telephone Number)

      (2) Have all other periodic reports required under section 13 or 15(d) of
the Securities Exchange Act of 1934 or section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
Registrant was required to file such report(s) been filed? If the answer is no,
identify report(s). 
                                                                  [X] Yes [ ] No


      (3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
                                                                [ ] Yes   [X] No

      If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.

                  (Name of Registrant as specified in charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.

Date: November 14, 2005                  By: /s/ JAMES F. MONGIARDO
                                         James F. Mongiardo, President

INSTRUCTION: The form may be signed by an executive officer of the Registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the Registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the Registrant shall be filed with the form.